Compare PHAR & AMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHAR | AMRC |
|---|---|---|
| Founded | 1988 | 2000 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2020 | 2010 |
| Metric | PHAR | AMRC |
|---|---|---|
| Price | $12.94 | $18.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $38.33 | $37.88 |
| AVG Volume (30 Days) | 4.5K | ★ 451.2K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,769,928,000.00 |
| Revenue This Year | $10.04 | $10.71 |
| Revenue Next Year | $2.51 | $9.07 |
| P/E Ratio | $3,041.22 | ★ N/A |
| Revenue Growth | N/A | ★ 28.76 |
| 52 Week Low | $10.55 | $15.52 |
| 52 Week High | $21.34 | $44.93 |
| Indicator | PHAR | AMRC |
|---|---|---|
| Relative Strength Index (RSI) | 38.08 | 27.22 |
| Support Level | $11.88 | N/A |
| Resistance Level | $13.61 | $33.98 |
| Average True Range (ATR) | 0.46 | 1.29 |
| MACD | -0.11 | -0.34 |
| Stochastic Oscillator | 3.92 | 9.12 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Ameresco Inc is an energy infrastructure solutions provider dedicated to helping customers reduce costs, enhance resilience, and decarbonize to net zero in the energy transition. Its comprehensive portfolio includes implementing smart energy efficiency solutions, upgrading aging infrastructure, and developing, constructing, and operating distributed energy resources. Its solutions range from upgrades to facility's energy infrastructure to the development, construction and operation of renewable energy plants combined with tailored financial solutions. Its segments include North America Regions, U.S. Federal, Renewable Fuels, Europe, and Others. The majority of the revenue is derived from North America Regions segment.